Evidence map›Paper›PMID 42811482›Full record

ArticleEmerging infectious diseases2026

Emergence of Genotype 2.3.1 Multidrug-Resistant Salmonella enterica Serovar Typhi Strain, West Africa, 2021-2025.

Elisabeth Njamkepo, Maria Pardos de la Gandara, Carolina Silva Nodari, Alexandra Moura, François-Xavier Weill

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elisabeth Njamkepo
Maria Pardos de la Gandara
Carolina Silva Nodari
Alexandra Moura
François-Xavier Weill

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2021, a genotype 2.3.1, ciprofloxacin-resistant, multidrug-resistant (MDR) Salmonella enterica serovar Typhi strain increasingly has been detected in persons returning from West Africa. This strain locally acquired 2 different MDR plasmids over a ≈25-year period, underwent chromosomal integration of the IncHI1 plasmid MDR region, and finally acquired a gyrA mutation.

Indexed as

Drug Resistance, Multiple, BacterialGenotypeSalmonella typhiTyphoid FeverAfrica, WesternAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsPlasmidsAnti-Bacterial Agentsantimicrobial resistancebacteriabacterial infectiongenomic surveillanceSalmonella entericaSenegalTyphityphoid feverWest Africa

Identifiers

PMID42811482
PMCPMC13632843

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.